A Phase 1 interventional study of Minimum Dose CT in Acute Dyspnoea, sponsored by University Health Network, Toronto. Completed. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2007-04-24.
Sponsored by University Health Network, Toronto · Phase 1, Interventional, and Diagnostic
A comparison of chest x-ray (CXR) and Minimum dose CT (MnDCT) in the acutely ill patient. The hypothesis is that MnDCT is more sensitive than CXR in the detection of acute findings in the acutely ill patient.
A comparison of chest x-ray (CXR) and Minimum dose CT (MnDCT) in a cohort of 100 patients admitted for acute respiratory distress. Chest radiography (CXR) is compared to Minimum Dose CT (MnDCT) for the detection of consolidation;lung nodules, heart failure.
656 studies on the registry are indexed under Dyspnea; 153 are open to participants now.
This study's enrollment of 100 is above the median of 48 across 430 interventional studies indexed under Dyspnea.
Browse Dyspnea studies →University Health Network, Toronto is the lead sponsor of 1,411 studies on the registry; 292 are open to participants now.
Of its 17 completed or terminated interventional studies of FDA-regulated products, 3 (18%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
A comparison of CXr and MnDCT in the detection of acute findings within the thorax
No study locations are listed for this record.
This study is completed, as verified in Sep 2005. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Health Network, Toronto